- Home
- Research Models
- B-NDG B2m KO
B-NDG B2m KO
Related publications
General studies
Oncology
General studies
Lan Gao, Shruti Sharma, Eugene Lin, Xiaoen Wang, Chengzhang Shang, Yuting Hu, W. Frank An, Mehma Kaur Chawla, Kaiqi Li, Qingcong Lin, Zhaoxue (Luke) Yu, Yujie Liu.,
Abstract 2945: Novel engineered B-NDG B2M/KO mice plus and steroid treated B-NDG Mice shows delayed GvHD response when engrafted with hPBMC,
Cancer Res 2021;81(13_Suppl):Abstract nr 2945.
W. Frank An, Lan Gao, Xiaoen Wang, Shruti Sharma, Kaiqi Li, Xiqiang Gao, Chengzhang Shang, Yuting Hu.,
Abstract 432: Development of a novel engineered B2M mouse strain on B-NDG background that specifically eliminates MHC I expression while retaining normal FcRn-mediated antibody retention,
Cancer Res 2020;80(16 Suppl):Abstract nr 432.
Oncology
Qingcong Lin, Madeline Lee, Yanan Guo, Tian Gan.,
Abstract 1052: The human immune system reconstituted B-NDG mouse models are ideal tools for CAR-T and therapeutic antibody preclinical efficacy evaluation,
In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3.
Hongmei Jiang;
Jianqiu Xiao;
Travis Rothrock,
Abstract 5195: BNDG B2m KO plus mouse model is a powerful tool for immunotherapy,
Cancer Res (2023) 83 (7_Supplement): 5195.
Subscribe to updates from Inotiv
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
